Core Viewpoint - Zhonghong Medical (300981) has shown a stable stock price with a closing price of 16.24 yuan as of August 18, 2025, with no change in percentage [1] Group 1: Stock Performance and Fund Flow - The stock's trading volume on August 18 was 166,900 hands, with a total transaction amount of 272 million yuan [1] - The net outflow of main funds was 9.0382 million yuan, accounting for 3.33% of the total transaction amount, while retail investors saw a net inflow of 16.3396 million yuan, representing 6.01% of the total [1] - Over the past five days, the stock has experienced fluctuations in fund flow, with significant net outflows from main and speculative funds on several days [2] Group 2: Company Financials and Industry Comparison - Zhonghong Medical's total market value is 6.965 billion yuan, ranking 54th in the medical device industry [3] - The company reported a net profit of 18.9211 million yuan for Q1 2025, a year-on-year increase of 1369.95%, with a main business revenue of 629 million yuan, up 15.45% year-on-year [3] - The company's gross profit margin stands at 13.36%, significantly lower than the industry average of 51.35%, indicating potential challenges in profitability [3]

Group 1 - The core viewpoint of the news is that Zhonghong Medical has experienced significant stock performance, with a 19.99% increase in share price, reaching 16.21 yuan per share, and a trading volume of 349 million yuan, indicating strong market interest [1] - Zhonghong Medical is primarily engaged in the production, research, and sales of disposable health protection products and medical sterile instruments, with six production bases and six research platforms [1] - The company exports its products to over 80 countries and regions globally and has received multiple international quality certifications, positioning itself as a leading comprehensive supplier of medical health products and services [1] Group 2 - As of March 31, Zhonghong Medical had 20,100 shareholders, with an average of 17,800 circulating shares per shareholder [2] - For the first quarter of 2025, Zhonghong Medical reported a revenue of 629 million yuan, representing a year-on-year growth of 15.45%, and a net profit attributable to shareholders of 18.92 million yuan, which is a remarkable increase of 1369.95% year-on-year [2]

证券之星消息，截至2025年8月5日收盘，中红医疗(300981)报收于13.87元，下跌2.53%，换手率3.6%， 成交量14.14万手，成交额1.98亿元。 | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-05 | 13.87 | -2.53% | -1425.79万 | -7.21% | 31.04万 | 0.16% | 1394.75万 | 7.06% | | 2025-08-04 | 14.23 -0.97% | | 673.91万 | 2.35% | 1845.88万 | 6.44% | -2519.80万 | -8.79% | | 2025-08-01 | 14.37 8.05% | | 2019.44万 | 6.74% | 1144.41万 | 3.82% | -3163.85万 | -10.56% | | 2025-07-31 | 13.30 0.00% | | -796.96万 | - ...

蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。公司主要产品包括冠脉植 介入、结构性心脏病以及和心脏介入手术相关的医疗器械产品，健康防护手套，以急救箱包为主的各类 紧急救援产品和一次性健康防护用品。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防 护手套年产销量及市场占有率均为全球第一。 5月19日，蓝帆医疗今日收盘5.31元，上涨1.14%，最新市净率0.66，创47天以来新低，总市值53.48亿 元。 股东方面，截至2025年4月18日，蓝帆医疗股东户数80811户，较上次减少95户，户均持股市值35.28万 元，户均持股数量2.76万股。 序号股票简称PE(TTM)PE(静)市净率总市值(元)21蓝帆医疗-19.83-12.000.6653.48亿行业平均 49.2647.464.56105.99亿行业中值36.7137.322.4947.70亿1天益医疗-1763.34-3020.401.8822.47亿2澳华内 镜-613.48307.694.9164.65亿3诺唯赞-411.11-486.242.2687.98亿4爱朋医疗-367.45279.154.4330.15 ...

4月14日，蓝帆医疗今日收盘4.68元，上涨2.63%，最新市净率0.55，总市值47.13亿元。 资金流向方面，4月14日，蓝帆医疗主力资金净流出239.68万元，近5日总体呈流出状态，5日共流出 2073.07万元。 来源：金融界 蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。公司主要产品包括冠脉植 介入、结构性心脏病以及和心脏介入手术相关的医疗器械产品，健康防护手套，以急救箱包为主的各类 紧急救援产品和一次性健康防护用品。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防 护手套年产销量及市场占有率均为全球第一。 最新一期业绩显示，2024年三季报，公司实现营业收入46.54亿元，同比29.85%；净利润-219822842.84 元，同比38.19%，销售毛利率17.17%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)23蓝帆医疗-10.90-8.290.5547.13亿行业平均 45.7149.434.75102.82亿行业中值29.9929.792.3746.97亿1硕世生物-1863.40-1863.401.1738.50亿2诺唯 赞-532.18-5 ...